JP2012500194A5 - - Google Patents

Download PDF

Info

Publication number
JP2012500194A5
JP2012500194A5 JP2011522551A JP2011522551A JP2012500194A5 JP 2012500194 A5 JP2012500194 A5 JP 2012500194A5 JP 2011522551 A JP2011522551 A JP 2011522551A JP 2011522551 A JP2011522551 A JP 2011522551A JP 2012500194 A5 JP2012500194 A5 JP 2012500194A5
Authority
JP
Japan
Prior art keywords
polypeptide
protein
peptide
allergen
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011522551A
Other languages
English (en)
Japanese (ja)
Other versions
JP5705113B2 (ja
JP2012500194A (ja
Filing date
Publication date
Priority claimed from PCT/GB2008/002780 external-priority patent/WO2009022156A2/en
Priority claimed from GB0814986A external-priority patent/GB0814986D0/en
Priority claimed from GB0815218A external-priority patent/GB0815218D0/en
Priority claimed from GBGB0901927.4A external-priority patent/GB0901927D0/en
Priority claimed from EP09251252.4A external-priority patent/EP2153841B2/en
Priority claimed from GB0912578A external-priority patent/GB0912578D0/en
Application filed filed Critical
Priority claimed from PCT/GB2009/001995 external-priority patent/WO2010018384A1/en
Publication of JP2012500194A publication Critical patent/JP2012500194A/ja
Publication of JP2012500194A5 publication Critical patent/JP2012500194A5/ja
Publication of JP5705113B2 publication Critical patent/JP5705113B2/ja
Application granted granted Critical
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011522551A 2008-08-15 2009-08-14 Ｉｌ−１０産生の刺激のためのアレルゲン由来のｔ細胞抗原 Expired - Fee Related JP5705113B2 (ja)

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
GBPCT/GB08/002779 2008-08-15
GBPCT/GB08/002778 2008-08-15
PCT/GB2008/002780 WO2009022156A2 (en) 2007-08-15 2008-08-15 Peptides for desensibilization against allergens
GBPCT/GB08/002780 2008-08-15
GB0814986A GB0814986D0 (en) 2008-08-15 2008-08-15 Peptide for il10 production
PCT/GB2008/002781 WO2009022157A2 (en) 2007-08-15 2008-08-15 Peptide with improved solubility
GB0814986.6 2008-08-15
GBPCT/GB08/002781 2008-08-15
PCT/GB2008/002778 WO2009022154A2 (en) 2007-08-15 2008-08-15 Peptide with multiple epitopes
PCT/GB2008/002779 WO2009022155A2 (en) 2007-08-15 2008-08-15 Peptide with reduced dimer formation
GB0815218A GB0815218D0 (en) 2008-08-20 2008-08-20 Ragweed peptides for vaccine
GB0815218.3 2008-08-20
GBGB0901927.4A GB0901927D0 (en) 2009-02-05 2009-02-05 Peptide for IL10 production
GB0901927.4 2009-02-05
EP09251252.4A EP2153841B2 (en) 2008-08-15 2009-05-01 Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy
EP09251252.4 2009-05-01
GB0912578A GB0912578D0 (en) 2009-07-20 2009-07-20 Peptide for IL-10 production
GB0912578.2 2009-07-20
PCT/GB2009/001995 WO2010018384A1 (en) 2008-08-15 2009-08-14 T-cell antigen peptide from allergen for stimulation of il-10 production

Publications (3)

Publication Number Publication Date
JP2012500194A JP2012500194A (ja) 2012-01-05
JP2012500194A5 true JP2012500194A5 (https=) 2012-10-04
JP5705113B2 JP5705113B2 (ja) 2015-04-22

Family

ID=41112622

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011522551A Expired - Fee Related JP5705113B2 (ja) 2008-08-15 2009-08-14 Ｉｌ−１０産生の刺激のためのアレルゲン由来のｔ細胞抗原

Country Status (4)

Country Link
US (2) US8821887B2 (https=)
EP (1) EP2331124A1 (https=)
JP (1) JP5705113B2 (https=)
WO (1) WO2010018384A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20150317T1 (hr) 2009-02-05 2015-04-24 Circassia Limited Peptidi trave za cjepivo
GB201002559D0 (en) 2010-02-15 2010-03-31 Circassia Ltd Birch peptides for vaccine
MX374963B (es) 2011-04-29 2025-03-06 Selecta Biosciences Inc Nanoportadores sintéticos tolerogénicos para reducir las respuestas de anticuerpos.
KR20140050698A (ko) 2011-07-29 2014-04-29 셀렉타 바이오사이언시즈, 인크. 체액성 및 세포독성 t 림프구(ctl) 면역 반응을 발생시키는 합성 나노운반체
GB201209862D0 (en) * 2012-06-01 2012-07-18 Circassia Ltd Cladosporium peptides
PL2914286T3 (pl) 2012-10-30 2022-01-31 Aravax Pty Ltd Nowe cząsteczki immunoterapeutyczne oraz ich zastosowania
BR122020023215B1 (pt) 2013-05-03 2022-11-22 Selecta Biosciences, Inc Composição e kit de nanocarreadores sintéticos tolerogênicos para reduzir ou prevenir anafilaxia em resposta a um antígeno não alergênico
WO2015042664A1 (en) 2013-09-25 2015-04-02 Monash University Novel immunotherapeutic composition and uses thereof
BR112016011930A2 (pt) * 2013-12-23 2017-09-26 Alk Abello As combinações de peptídeos e seus usos em tratamento de alergia de ácaro de poeira
JP7242180B2 (ja) 2014-09-07 2023-03-20 セレクタ バイオサイエンシーズ インコーポレーテッド 抗ウイルス導入ベクター免疫応答を減弱化するための方法および組成物
AU2016241035B2 (en) * 2015-03-30 2018-10-04 Osaka University Immunizing peptide, method for producing immunizing peptide, pharmaceutical composition for immune disease containing same, and method for treating immune disease
ES3036482T3 (en) 2017-03-11 2025-09-19 Cartesian Therapeutics Inc Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
AU2020287627A1 (en) 2019-06-04 2021-11-18 Selecta Biosciences, Inc. Formulations and doses of PEGylated uricase
US20220119447A1 (en) * 2019-10-18 2022-04-21 PELL Bio-Med Technology Co., Ltd. Peptide and for treating inflammatory disease and pain using the same

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776761A (en) 1989-03-17 1998-07-07 Immulogic Pharmaceutical Corporation Nucleic acids encoding allergenic proteins from ragweed
WO1990011293A1 (en) 1989-03-17 1990-10-04 Immulogic Pharmaceutical Corporation Allergenic proteins from ragweed and uses therefor
DE69131131T2 (de) * 1990-09-11 1999-10-14 Institute For Child Health Research Klonierung und sequenzierung von dermatophagoiden-antigenen (hausstaubmilben)
WO1994001560A1 (en) 1991-07-12 1994-01-20 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from japanese cedar pollen
WO1994024281A1 (en) 1993-04-14 1994-10-27 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
DE69233772D1 (de) * 1991-10-16 2009-11-12 Merck Patent Gmbh T-zell epitopen von den wichtigsten allergene von dermatophagoides (hausmilbe)
US6441157B1 (en) 1991-11-15 2002-08-27 University Of Melbourne Nucleic acid sequences encoding protein allergens of the species Cynodon dactylon
CA2117779A1 (en) 1992-04-09 1993-10-28 Mei-Chang Kuo T cell epitopes of the major allergens from ambrosia artemisifolia
DE69333979T2 (de) * 1993-04-14 2006-12-21 Heska Corp.(n.d.Ges, d.Staates Delaware), Loveland T-zell epitope der hauptallergene von dermatophagoides (hausstaubmilbe)
US5968526A (en) 1994-04-14 1999-10-19 Immulogic Pharamaceutical Corporation T cell epitopes of the major allergens from Dermatophagoides (house dust mite)
DK0755407T3 (da) 1994-04-14 2007-08-06 Merck Patent Gmbh Farmaceutisk peptidformuleringer til behandling af stövmideallergi
US7112333B1 (en) 1994-08-05 2006-09-26 Heska Corporation T cell epitopes of ryegrass pollen allergen
AU4146796A (en) * 1994-10-27 1996-05-23 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from ambrosia artemisiifolia
IL115744A (en) 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39
GB2348808B (en) 1998-01-09 2003-03-19 Circassia Ltd Methods and compositions for desensitisation
US6989146B2 (en) 2000-08-09 2006-01-24 The Regents Of The University Of California Stress proteins and peptides and methods of use thereof
GB0108752D0 (en) 2001-04-06 2001-05-30 Isis Innovation Peptide epitopes and uses thereof
EP1453539B1 (en) 2001-12-05 2008-11-19 Circassia Limited Immunotherapeutic methods and systems
AUPS148202A0 (en) 2002-04-02 2002-05-09 Monash University Immunotherapeutic and immunoprophylactic reagents
WO2003088997A2 (en) 2002-04-22 2003-10-30 Universiteit Utrecht Holding B.V. Reduction of unwanted immune reactions
GB0210741D0 (en) 2002-05-10 2002-06-19 Medical Res Council Methods of therapy
FR2841906B1 (fr) 2002-07-05 2006-08-18 Stallergenes Sa Molecule d'acide nucleique codant une preproproteine d'allergene d'un acarien du genre dermatophagoides ou euroglyphus et son utilisation pour la production dudit allergene dans les plantes
GB0308988D0 (en) 2003-04-17 2003-05-28 Univ Singapore Molecule
WO2006075253A2 (en) 2005-01-11 2006-07-20 Commissariat A L'energie Atomique Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides.
WO2006132607A1 (en) 2005-06-10 2006-12-14 National University Of Singapore Mutant allergen(s)
US20070092532A1 (en) 2005-10-25 2007-04-26 Board Of Trustees Operating Michigan State University Arthritis vaccines and methods
ES2405552T3 (es) 2005-11-29 2013-05-31 Actogenix N.V. Inducción de tolerancia mucosa a antiantígenos de células beta de islotes pancreáticos
EP1958645A1 (en) 2007-02-13 2008-08-20 Biomay AG Peptides derived from the major allergen of ragweed (Ambrosia artemisiifolia) and uses thereof
WO2008139163A1 (en) 2007-05-09 2008-11-20 Circassia Limited Prognostic assay for determining t cell response to hla antigens and use thereof in field of tissue transplantation
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
NZ583362A (en) 2007-08-15 2012-06-29 Circassia Ltd Peptide with reduced dimer formation
EP2042193A1 (en) 2007-09-28 2009-04-01 Biomay AG RNA Vaccines
ES2378870T5 (es) * 2008-08-15 2016-02-03 Circassia Limited Vacuna que comprende péptidos Amb a 1 para uso en el tratamiento de alergia a ambrosía

Similar Documents

Publication Publication Date Title
JP2012500194A5 (https=)
CN102227214B (zh) 二聚体形成减少的组合物
JP5755398B2 (ja) 伸長されたｇｌｐ−１化合物
ES2532116T3 (es) Péptidos derivados con A-B-C-D y sus usos terapéuticos
US20230073594A1 (en) Lactoferrin compositions and methods for modulation of t cell subtypes and treatment of autoimmune diseases
Virtanen et al. Mammalian lipocalin allergens–insights into their enigmatic allergenicity
JP5209463B2 (ja) アシル化ｇｌｐ−１化合物
RU2657573C2 (ru) Применение долгодействующих пептидов glp-1
US8580918B2 (en) Peptidic GLP-2 agonists
AU2009248041B2 (en) Long-acting Y2 and/or Y4 receptor agonists
US8821887B2 (en) T-cell antigen peptide from allergen for stimulation of IL-10 production
HRP20100662T1 (hr) Peptidi za desenzibilizaciju protiv alergena
JP2010536333A5 (https=)
US20190070287A1 (en) Tolerance therapeutic for treating polypeptide induced immune activation
US20150141336A1 (en) Pancreatic Peptide Compounds and Use
HRP20120206T4 (hr) Cjepivo koje sadrži amb a 1 peptide za uporabu u lijeäśenju alergije na ambroziju
JP2012516693A5 (https=)
KR20190017017A (ko) 프로테아제-내성 모노-지질화된 펩타이드
FR2744123A1 (fr) Molecules biologiquement actives plus particulierement peptidiques ayant un effet potentialisateur de l'activite biologique de l'hormone de croissance
US20250388638A1 (en) Compositions and methods for oral delivery
JP2007512812A (ja) 羊膜由来ペプチドおよびその使用
AU2015227499A1 (en) Compositions with reduced dimer formation